Vamil Divan
Stock Analyst at Guggenheim
(4.77)
# 571
Out of 4,423 analysts
966
Total ratings
57.9%
Success rate
12.2%
Average return
Main Sectors:
Stocks Rated by Vamil Divan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABSI Absci | Reiterated: Buy | $10 → $15 | $7.41 | +102.43% | 4 | Jun 14, 2026 | |
| JNJ Johnson & Johnson | Maintained: Buy | $266 | $228.39 | +16.47% | 51 | Jun 5, 2026 | |
| TVTX Travere Therapeutics | Reiterated: Buy | $56 | $55.15 | +1.54% | 27 | Jun 5, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $56 | $35.09 | +59.59% | 14 | Jun 5, 2026 | |
| MRK Merck & Co. | Maintained: Buy | $140 | $113.87 | +22.95% | 48 | Jun 2, 2026 | |
| PFE Pfizer | Maintained: Buy | $36 | $25.21 | +42.80% | 117 | Jun 1, 2026 | |
| JBIO Jade Biosciences | Reiterated: Buy | $32 → $47 | $16.82 | +179.43% | 8 | Jun 1, 2026 | |
| ASMB Assembly Biosciences | Reiterated: Buy | $43 | $24.44 | +75.94% | 12 | May 28, 2026 | |
| SVRA Savara | Reiterated: Buy | $11 | $5.50 | +100.00% | 9 | May 12, 2026 | |
| UNCY Unicycive Therapeutics | Maintained: Buy | $40 → $37 | $6.85 | +440.15% | 7 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $124 | $79.49 | +55.99% | 19 | May 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 → $226 | $95.80 | +135.91% | 15 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 38.00 | $11.50 | +230.43% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $351 → $340 | $337.60 | +0.71% | 7 | May 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $249 | $216.49 | +15.02% | 128 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $5.38 | +104.46% | 8 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $3.92 | +104.08% | 9 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $7 | $1.83 | +282.51% | 2 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $10.65 | n/a | 4 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €9.00 | $10.66 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $5 | $4.05 | n/a | 4 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.168 | n/a | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $26 | $6.73 | n/a | 6 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1,098.57 | n/a | 95 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 13 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $82.49 | n/a | 5 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.95 | n/a | 7 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 | $250.50 | n/a | 15 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $6.63 | n/a | 31 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $27 | $21.62 | n/a | 20 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $44.99 | n/a | 72 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $10 | $2.84 | n/a | 11 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $68.55 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $738 | $609.94 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $139 | $42.38 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $265 | $451.63 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $16.58 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $31.43 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $95 | $158.29 | n/a | 30 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $26.21 | n/a | 4 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $36.87 | n/a | 1 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.09 | n/a | 2 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $3.54 | n/a | 3 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $31.48 | n/a | 55 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $59 → $55 | $54.00 | n/a | 45 | May 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $28.32 | n/a | 10 | Dec 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $92.20 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $11.91 | n/a | 6 | Aug 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $29 | $3.15 | n/a | 11 | Mar 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $312 → $322 | $196.58 | n/a | 2 | Aug 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $0.955 | n/a | 1 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $35 → $30 | $4.54 | n/a | 6 | Feb 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $198 → $230 | $161.93 | n/a | 7 | Jan 28, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $123.76 | n/a | 1 | Apr 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $48 | $127.06 | n/a | 1 | Mar 5, 2013 |
Absci
Jun 14, 2026
Reiterated: Buy
Price Target: $10 → $15
Current: $7.41
Upside: +102.43%
Johnson & Johnson
Jun 5, 2026
Maintained: Buy
Price Target: $266
Current: $228.39
Upside: +16.47%
Travere Therapeutics
Jun 5, 2026
Reiterated: Buy
Price Target: $56
Current: $55.15
Upside: +1.54%
Vera Therapeutics
Jun 5, 2026
Reiterated: Buy
Price Target: $56
Current: $35.09
Upside: +59.59%
Merck & Co.
Jun 2, 2026
Maintained: Buy
Price Target: $140
Current: $113.87
Upside: +22.95%
Pfizer
Jun 1, 2026
Maintained: Buy
Price Target: $36
Current: $25.21
Upside: +42.80%
Jade Biosciences
Jun 1, 2026
Reiterated: Buy
Price Target: $32 → $47
Current: $16.82
Upside: +179.43%
Assembly Biosciences
May 28, 2026
Reiterated: Buy
Price Target: $43
Current: $24.44
Upside: +75.94%
Savara
May 12, 2026
Reiterated: Buy
Price Target: $11
Current: $5.50
Upside: +100.00%
Unicycive Therapeutics
May 12, 2026
Maintained: Buy
Price Target: $40 → $37
Current: $6.85
Upside: +440.15%
May 10, 2026
Reiterated: Buy
Price Target: $124
Current: $79.49
Upside: +55.99%
May 7, 2026
Reiterated: Buy
Price Target: $230 → $226
Current: $95.80
Upside: +135.91%
May 6, 2026
Reiterated: Buy
Price Target: kr 38.00
Current: $11.50
Upside: +230.43%
May 3, 2026
Maintained: Hold
Price Target: $351 → $340
Current: $337.60
Upside: +0.71%
Apr 30, 2026
Reiterated: Buy
Price Target: $249
Current: $216.49
Upside: +15.02%
Apr 16, 2026
Maintained: Buy
Price Target: $13 → $11
Current: $5.38
Upside: +104.46%
Mar 20, 2026
Maintained: Buy
Price Target: $8
Current: $3.92
Upside: +104.08%
Jul 13, 2025
Maintained: Buy
Price Target: $6 → $7
Current: $1.83
Upside: +282.51%
May 29, 2025
Maintained: Hold
Price Target: n/a
Current: $10.65
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: €9.00
Current: $10.66
Upside: n/a
Mar 19, 2025
Maintained: Buy
Price Target: $6 → $5
Current: $4.05
Upside: n/a
May 6, 2024
Maintained: Hold
Price Target: n/a
Current: $0.168
Upside: n/a
Jun 15, 2023
Maintained: Buy
Price Target: $50 → $26
Current: $6.73
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $1,098.57
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $82.49
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $6.95
Upside: n/a
Jun 27, 2022
Maintained: Buy
Price Target: $49
Current: $250.50
Upside: n/a
Jun 21, 2022
Maintained: Buy
Price Target: $15
Current: $6.63
Upside: n/a
Jun 17, 2022
Rated: Hold
Price Target: $27
Current: $21.62
Upside: n/a
May 24, 2022
Reiterated: Buy
Price Target: $36
Current: $44.99
Upside: n/a
May 24, 2022
Maintained: Buy
Price Target: $20 → $10
Current: $2.84
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $52
Current: $68.55
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $738
Current: $609.94
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $139
Current: $42.38
Upside: n/a
May 22, 2022
Initiated Coverage: Hold
Price Target: $265
Current: $451.63
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $12
Current: $16.58
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $6
Current: $31.43
Upside: n/a
May 4, 2022
Maintained: Hold
Price Target: $95
Current: $158.29
Upside: n/a
Sep 21, 2021
Reiterated: Buy
Price Target: $58
Current: $26.21
Upside: n/a
May 7, 2021
Maintained: Buy
Price Target: $37
Current: $36.87
Upside: n/a
Jul 10, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $1.09
Upside: n/a
Jul 10, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $3.54
Upside: n/a
Jul 10, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $31.48
Upside: n/a
May 29, 2019
Maintained: Hold
Price Target: $59 → $55
Current: $54.00
Upside: n/a
Dec 13, 2018
Upgraded: Buy
Price Target: n/a
Current: $28.32
Upside: n/a
Nov 27, 2017
Initiated Coverage: Buy
Price Target: $19
Current: $92.20
Upside: n/a
Aug 23, 2017
Upgraded: Hold
Price Target: n/a
Current: $11.91
Upside: n/a
Mar 20, 2017
Upgraded: Hold
Price Target: $29
Current: $3.15
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $312 → $322
Current: $196.58
Upside: n/a
Oct 26, 2015
Rated: Buy
Price Target: $29
Current: $0.955
Upside: n/a
Feb 4, 2015
Downgraded: Sell
Price Target: $35 → $30
Current: $4.54
Upside: n/a
Jan 28, 2015
Reiterated: Buy
Price Target: $198 → $230
Current: $161.93
Upside: n/a
Apr 14, 2014
Reiterated: Buy
Price Target: n/a
Current: $123.76
Upside: n/a
Mar 5, 2013
Initiated Coverage: Buy
Price Target: $48
Current: $127.06
Upside: n/a